Početna › Ateroskleroza › Texas › Houston
Kliničke studije za Ateroskleroza u gradu Houston, TX
10 studija za Ateroskleroza traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
U tijeku regrutacijaFaza 2
- Cardiovascular Specialists of Willowbrook, Houston
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
U tijeku regrutacijaFaza 2
- East Texas Cardiology PA, Houston
- Cardiovascular Specialists of Willowbrook, Houston
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
U tijeku regrutacijaFaza 3
- Center for Cardiometabolic Disease Prevention/Baylor College of Medicine, Houston
- Orion Medical - Houston, Houston
- Research Physicians Network, LLC, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
U tijeku regrutacijaFaza 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- i još 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
U tijeku regrutacijaFaza 2/3
- Clinical Research Strategies, Houston
- DaVita Clinical Research, Houston
- Aqua Research Institute, Houston
- i još 4
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
U tijeku regrutacijaFaza 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- i još 4
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
U tijeku regrutacijaFaza 3
- Kelsey Seybold Research Foundation, Houston
Pelacarsen Roll-over Extension Program
U tijeku regrutacijaFaza 3
- Angiocardiac Care of Texas PA, Houston
- Dallas Heart and Vascular Consultants PA, Houston
- Dallas Heart and Vascular Consultants PA, Houston
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
U tijeku regrutacijaFaza 4
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
U tijeku regrutacijaFaza 2
- UT Health Houston, Houston
Studije za Ateroskleroza u drugim gradovima
- Boston, MA10 studija
- Washington, DC9 studija
- Orlando, FL8 studija
- Arlington, VA8 studija
- Hialeah, FL8 studija
- Durham, NC7 studija
- Dallas, TX7 studija
- Memphis, TN7 studija
- Miami, FL7 studija
- Las Vegas, NV7 studija
- San Diego, CA6 studija
- Santa Monica, CA6 studija
Ostale studije u gradu Houston
- Nemikrocelularni karcinom pluća145 studija
- Rak dojke126 studija
- Rak (sve vrste)121 studija
- Metastatski karcinom104 studija
- Kolorektalni rak102 studija
- Rak jajnika89 studija
- Akutna mijeloična leukemija85 studija
- Rak pluća78 studija
- Rak prostate76 studija
- Rak endometrija68 studija
- Rak gušterače61 studija
- Melanom59 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.